Related Experiment Video
Updated: May 23, 2026

09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Statins and cardiovascular risk in rheumatic diseases
International Journal of Immunopathology and Pharmacology
|April 18, 2012
Summary
Statins may help reduce cardiovascular events in chronic inflammatory rheumatic diseases due to their anti-inflammatory effects. However, altered lipid metabolism in these conditions requires further research for optimal statin therapy.
Area of Science:
- Rheumatology
- Cardiology
- Pharmacology
Background:
- Chronic inflammatory rheumatic diseases (CIRDs) elevate cardiovascular (CV) atherosclerotic event risk.
- Inflammation in CIRDs accelerates atherogenesis, necessitating therapies beyond traditional risk factor control.
Discussion:
- Statins, by inhibiting cholesterol biosynthesis, reduce CV morbidity and mortality.
- Beyond lipid-lowering, statins possess pleiotropic anti-inflammatory and immunomodulatory effects beneficial for CIRDs.
Key Insights:
- Inflammation in CIRDs complicates lipid metabolism, potentially rendering standard cholesterol targets inadequate.
- Statins offer a dual benefit of lipid reduction and anti-inflammatory action in CIRDs.
Outlook:
- Further large-scale trials are essential to determine the precise benefits and health utility of statins in CIRDs.
- Refining therapeutic strategies for statin use in CIRDs requires a deeper understanding of their complex lipid profiles.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...